Skip to main content
. Author manuscript; available in PMC: 2012 Sep 23.
Published in final edited form as: Mol Cancer Ther. 2010 Aug 3;9(8):2322–2332. doi: 10.1158/1535-7163.MCT-09-1212

Table 1.

Pancreas cancer cell lines characteristics and their dasatinib IC50

Cell Line Derivation Genetic background IC50 (nmol/L)
MiaPaca2 Primary Mutant K-ras, mutant p53, wt smad4 51.28
PANC1 Primary Mutant K-ras, mutant p53, wt smad4 45.68
AsPC1 Metastasis (ascites) Mutant K-ras, wt p53, wt smad4 44.97
CEPAC1 Metastasis (liver) Mutant K-ras, wt p53, mutant smad4 24.99
Capan1 Metastasis (liver) Mutant K-ras, ND p53, mutant smad4 9.604
SW1990 Metastasis (spleen) Mutant K-ras, wt p53, ND smad4 5.106
Capan2 Primary Mutant K-ras, wt p53, wt smad4 4.872
HPAC Primary Mutant K-ras, wt p53, wt smad4 2.791
BxPC3 Primary Wt K-ras, mutant p53, mutant smad4 2.809

WT: wild type; ND: not determined

HHS Vulnerability Disclosure